Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 216,858,896
  • Shares Outstanding, K 1,734,455
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • EBIT $ 8,588 M
  • EBITDA $ 11,831 M
  • 60-Month Beta 0.73
  • Price/Sales 5.09
  • Price/Cash Flow 21.21
  • Price/Book 5.34

Options Overview Details

View History
  • Implied Volatility 16.47% ( -0.08%)
  • Historical Volatility 21.35%
  • IV Percentile 7%
  • IV Rank 16.11%
  • IV High 29.56% on 10/08/24
  • IV Low 13.95% on 11/27/24
  • Put/Call Vol Ratio 0.43
  • Today's Volume 35,595
  • Volume Avg (30-Day) 16,721
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 178,735
  • Open Int (30-Day) 201,087

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.07
  • Number of Estimates 8
  • High Estimate 1.08
  • Low Estimate 1.05
  • Prior Year 0.98
  • Growth Rate Est. (year over year) +9.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.86 +12.78%
on 01/15/25
125.67 -0.51%
on 01/24/25
+10.27 (+8.95%)
since 12/24/24
3-Month
110.86 +12.78%
on 01/15/25
125.67 -0.51%
on 01/24/25
+8.49 (+7.29%)
since 10/24/24
52-Week
99.71 +25.39%
on 07/18/24
125.67 -0.51%
on 01/24/25
+14.26 (+12.87%)
since 01/24/24

Most Recent Stories

More News
Top Stock Reports for Cisco, Abbott & Coca-Cola

Friday, January 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems,...

DFS : 202.10 (+0.57%)
ABT : 125.03 (+1.47%)
CSCO : 62.23 (unch)
FI : 208.84 (+1.14%)
KO : 61.92 (+0.63%)
MMM : 149.43 (-0.13%)
Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

ABT : 125.03 (+1.47%)
JNJ : 146.82 (+0.12%)
My Top 5 Stocks to Buy in Early 2025

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term. The healthcare space is a great place to look for...

ABT : 125.03 (+1.47%)
CRSP : 43.42 (-1.83%)
LLY : 785.41 (+2.45%)
ISRG : 584.05 (-4.04%)
PFE : 26.09 (+0.31%)
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript

ABT earnings call for the period ending December 31, 2024.

ABT : 125.03 (+1.47%)
Abbott: Q4 Earnings Snapshot

Abbott: Q4 Earnings Snapshot

ABT : 125.03 (+1.47%)
Nasdaq Futures Climb on Trump’s AI Plan and Upbeat Netflix Earnings

March Nasdaq 100 E-Mini futures (NQH25) are trending up +0.82% this morning as optimism over more artificial intelligence spending under Donald Trump and strong quarterly results from Netflix boosted sentiment....

NFLX : 977.59 (-0.74%)
NVDA : 142.62 (-3.12%)
UAL : 105.00 (+1.94%)
AAPL : 222.78 (-0.39%)
ADS.D.DX : 253.700 (-1.76%)
IBKR : 218.99 (+5.01%)
KMI : 30.27 (-0.69%)
JNJ : 146.82 (+0.12%)
ORCL : 183.60 (-1.54%)
MMM : 149.43 (-0.13%)
ABT : 125.03 (+1.47%)
VST : 191.11 (-0.41%)
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever

Many products sold by companies aren't must-have items. However, healthcare is a necessity. And the healthcare sector is poised to grow over the next decade and beyond with aging populations around the...

ABT : 125.03 (+1.47%)
VRTX : 439.62 (-0.03%)
ABBV : 170.30 (-0.22%)
ISRG : 584.05 (-4.04%)
5 Stocks to Watch for Earnings This Week

Earnings season is moving past the big banks with other S&P 500 companies on deck this week. And while we will still get some bank earnings, the rest will be in a diverse group of industries including...

NFLX : 977.59 (-0.74%)
ABT : 125.03 (+1.47%)
UNP : 248.78 (+0.29%)
AAL : 16.96 (-0.41%)
ISRG : 584.05 (-4.04%)
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

When most of us think of investing in stocks, we think of the potential gains -- or unfortunately, in some cases, losses -- that might follow. A particular stock will rise or fall, and we'll benefit or...

ABT : 125.03 (+1.47%)
$SPX : 6,101.24 (-0.29%)
JNJ : 146.82 (+0.12%)
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever

Investors seeking a steadily growing passive income stream want to turn their heads toward the healthcare sector. Unlike with enterprise software sales or consumer goods, spending on healthcare tends to...

ABT : 125.03 (+1.47%)
AZN : 69.06 (+0.67%)
JNJ : 146.82 (+0.12%)
ABBV : 170.30 (-0.22%)
MDT : 90.19 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 129.90
2nd Resistance Point 127.78
1st Resistance Point 126.41
Last Price 125.03
1st Support Level 122.92
2nd Support Level 120.80
3rd Support Level 119.43

See More

52-Week High 125.67
Last Price 125.03
Fibonacci 61.8% 115.75
Fibonacci 50% 112.69
Fibonacci 38.2% 109.63
52-Week Low 99.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar